Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Icu Medical (ICUI) Revenue (2016 - 2025)

Historic Revenue for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to $537.0 million.

  • Icu Medical's Revenue fell 885.05% to $537.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 billion, marking a year-over-year decrease of 84.33%. This contributed to the annual value of $2.4 billion for FY2024, which is 544.1% up from last year.
  • As of Q3 2025, Icu Medical's Revenue stood at $537.0 million, which was down 885.05% from $548.9 million recorded in Q2 2025.
  • Icu Medical's Revenue's 5-year high stood at $629.8 million during Q4 2024, with a 5-year trough of $318.0 million in Q1 2021.
  • Over the past 5 years, Icu Medical's median Revenue value was $561.0 million (recorded in 2022), while the average stood at $522.5 million.
  • Its Revenue has fluctuated over the past 5 years, first skyrocketed by 7790.19% in 2022, then crashed by 885.05% in 2025.
  • Quarter analysis of 5 years shows Icu Medical's Revenue stood at $340.5 million in 2021, then skyrocketed by 69.74% to $578.0 million in 2022, then rose by 1.7% to $587.9 million in 2023, then rose by 7.14% to $629.8 million in 2024, then fell by 14.74% to $537.0 million in 2025.
  • Its Revenue stands at $537.0 million for Q3 2025, versus $548.9 million for Q2 2025 and $604.7 million for Q1 2025.